Article Text

Download PDFPDF
Psychosocial aspects of the functional gastrointestinal disorders

Abstract

The functional gastrointestinal disorders (FGID) are the most frequent conditions seen in gastroenterology practice and comprise a major portion of primary care. Psychosocial factors are important in these disorders with regard to: (1) their effects on gut physiology; (2) their modulation of the symptom experience; (3) their influence on illness behavior; (4) their impact on outcome; and (5) the choice of the therapeutic approach. This paper provides a review and consensus of the existing literature by gastroenterologists, psychiatrists, psychologists, physiologists, and health services investigators. Evidence is provided to support the biopsychosocial model as a basis for understanding and treating these disorders, and epidemiological and clinical information on the relations of psychosocial factors to gut physiology, symptom presentation, health behavior, and outcome is offered. Features of motility, personality, abuse history, health concerns, and treatment-seeking differ between patients with FGID and healthy controls, but they are not specific to FGID. They occur in other patients with chronic medical conditions and/or psychiatric disorders. Review of treatment trials indicates clear support for psychotherapeutic treatments, especially in the long term, as well as some evidence for the benefit of antidepressants in FGID, even in the absence of improvements in mood.

  • functional gastrointestinal disorders
  • psychologic assessment
  • psychiatric diagnosis
  • psychosocial factors
  • health-related quality of life
  • psychological treatment
  • psychopharmacological treatment
  • Rome II
  • Abbreviations used in this paper

    FGID
    functional gastrointestinal disorders
    CNS
    central nervous system
    IBS
    irritable bowel syndrome
    MMC
    migrating motor complex
    PET
    positron emission tomography
    HRQOL
    health-related quality of life
    CBT
    cognitive–behavioral therapy
    SSRI
    selective serotonin reuptake inhibitor
    TCA
    tricyclic antidepressant
  • Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Abbreviations used in this paper

    FGID
    functional gastrointestinal disorders
    CNS
    central nervous system
    IBS
    irritable bowel syndrome
    MMC
    migrating motor complex
    PET
    positron emission tomography
    HRQOL
    health-related quality of life
    CBT
    cognitive–behavioral therapy
    SSRI
    selective serotonin reuptake inhibitor
    TCA
    tricyclic antidepressant
  • View Full Text